Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | CASP6 | P55212 | 1/20 | 0.51 |
| ▸ | TPMT | P51580 | 1/20 | 0.50 |
| ▸ | HCAR3 | P49019 | 5/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | TTR | P02766 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL503451 | 0.87 | TSHR (0.65) | TSHRCASP6TPMTHCAR3LMNA | |
| SCHEMBL30601650 | 0.86 | LMNA (0.46) | TSHRCASP6LMNAMAPTALDH1A1 | |
| SCHEMBL30601690 | 0.85 | PARP1 (0.49) | TSHRLMNAGAAMAPTALDH1A1 | |
| SCHEMBL26626574 | 0.85 | PARP1 (0.49) | TSHRLMNAGAAMAPTALDH1A1 | |
| SCHEMBL26626614 | 0.85 | MEN1 (0.45) | TSHRCASP6LMNAMAPTALDH1A1 | |
| SCHEMBL30601730 | 0.85 | MEN1 (0.45) | TSHRCASP6LMNAMAPTALDH1A1 | |
| SCHEMBL3582465 | 0.82 | TSHR (0.64) | TSHRCASP6TPMTHCAR3LMNA | |
| SCHEMBL30158739 | 0.82 | CASP6 (0.55) | TSHRCASP6TPMTHCAR3LMNA | |
| SCHEMBL2671510 | 0.82 | VCAM1 (0.50) | TPMTLMNAGAAMAPTALDH1A1 | |
| SCHEMBL4342619 | 0.81 | GSK3B (0.45) | TSHRLMNAGAAMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4344577-A1 | COATED SILVER PRODUCTS AND METHODS FOR MAKING THE SAME | Nexdot (FR) | 2024-04-03 | — | — | EP | claimed |
| CN-117626039-A | High-strength plastic multistage hybrid heterostructure titanium-based composite material and preparation method thereof | 西安稀有金属材料研究院有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-116876057-A | Titanium-aluminum composite part heat-cracking-resistant oxide film and preparation process thereof | 东莞市慧泽凌化工科技有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-113020604-A | High-strength wear-resistant high-temperature-resistant titanium-aluminum oxide alloy material and preparation method thereof | 西安建筑科技大学 | 2021-06-25 | — | — | CN | claimed |
| CN-111020194-A | Method for synthesizing titanium-aluminum alloy from waste lithium titanate anode and cathode powder | 银隆新能源股份有限公司 | 2020-04-17 | — | — | CN | claimed |
| CN-104707622-B | A kind of preparation method of selective acetylene hydrocarbon hydrogenation catalyst | 中国石油化工股份有限公司 | 2017-08-22 | — | — | CN | claimed |
| US-9553157-B2 | Diffusion-controlled oxygen depletion of semiconductor contact interface | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-01-24 | — | — | US | claimed |
| US-20160027889-A1 | DIFFUSION-CONTROLLED OXYGEN DEPLETION OF SEMICONDUCTOR CONTACT INTERFACE | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2016-01-28 | — | — | US | claimed |
| US-9187511-B2 | Titanium-aluminum alloy deposition with titanium-tetrahydroaluminate bimetallic molecules | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude (FR) | 2015-11-17 | — | — | US | claimed |
| CN-103201237-B | Monolithic ceramic body with mixed-oxide edge region and metallic surface, method for the production thereof, and use thereof | CERAMOSS GMBH (AT) | 2015-09-30 | — | — | CN | claimed |
| US-20150270179-A1 | DIFFUSION-CONTROLLED OXYGEN DEPLETION OF SEMICONDUCTOR CONTACT INTERFACE | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2015-09-24 | — | — | US | claimed |
| CN-104353443-A | Method for preparing styrene catalyst by ethylbenzene dehydrogenation | UNIV SHENYANG CHEMICAL TECH | 2015-02-18 | — | — | CN | claimed |
| EP-1514852-B1 | Transparent protective layer for an article | SCHOTT AG (DE) | 2014-11-19 | — | — | EP | claimed |
| US-20130295298-A1 | TITANIUM-ALUMINUM ALLOY DEPOSITION WITH TITANIUM-TETRAHYDROALUMINATE BIMETALLIC MOLECULES | L'AIR LIQUIDE, SOCIETE ANONYME POUR I'ETUDE ET I'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2013-11-07 | — | — | US | claimed |
| CN-103201237-A | Monolithic ceramic body with mixed-oxide edge region and metallic surface, method for the production thereof, and use thereof | CERAMOSS GMBH | 2013-07-10 | — | — | CN | claimed |
| US-20130146134-A1 | SOLAR CELL WITH NANOLAMINATED TRANSPARENT ELECTRODE AND METHOD OF MANUFACTURING THE SAME | NATIONAL APPLIED RESEARCH LABORATORIES (TW) | 2013-06-13 | — | — | US | claimed |
| CN-101864556-A | High dielectric coefficient titanium-aluminum oxide film and preparation method and application thereof | NANJING UNIVERSITY OF TECHNOLOGY | 2010-10-20 | — | — | CN | claimed |
| US-20060127699-A1 | Protective layer and process and arrangement for producing protective layers | MOELLE CHRISTOPH | 2006-06-15 | — | — | US | claimed |
| US-20250313556-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | RETUNE PHARMA, INC. | 2025-10-09 | — | — | US | disclosed |
| EP-0181588-A2 | Alkyl-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids, process for their preparation, and antibacterial agents containing them | BAYER AG (DE) | 1986-05-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130295298-A1 | TITANIUM-ALUMINUM ALLOY DEPOSITION WITH TITANIUM-TETRAHYDROALUMINATE BIMETALLIC MOLECULES | TIAL1, TLL2, ACSL3 | TSHR 2142/4885CASP6 1865/4885TPMT 1457/4885 |
| US-20250313556-A1 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | KIT, PRKCH, PRKCB | TSHR 4310/4885CASP6 1330/4885TPMT 1549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.